| Primary |
| Hypertension |
17.6% |
| Gastritis |
15.2% |
| Gastric Ulcer |
8.7% |
| Constipation |
5.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.9% |
| Tonsillitis |
4.4% |
| Insomnia |
4.3% |
| Gastroenteritis |
4.0% |
| Hyperlipidaemia |
4.0% |
| Diabetes Mellitus |
3.9% |
| Pneumonia |
3.8% |
| Acute Myocardial Infarction |
3.2% |
| Angina Pectoris |
3.1% |
| Depression |
3.0% |
| Cerebral Infarction |
2.9% |
| Reflux Oesophagitis |
2.7% |
| Myasthenia Gravis |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Prophylaxis |
2.3% |
| Abdominal Pain Upper |
2.2% |
|
| Liver Disorder |
20.0% |
| Rhabdomyolysis |
13.2% |
| Interstitial Lung Disease |
9.2% |
| Stevens-johnson Syndrome |
7.0% |
| Drug Eruption |
6.5% |
| Ventricular Tachycardia |
4.1% |
| Erythema Multiforme |
3.8% |
| Pancytopenia |
3.8% |
| White Blood Cell Count Decreased |
3.5% |
| Aplastic Anaemia |
3.2% |
| Renal Failure Acute |
3.2% |
| Toxic Epidermal Necrolysis |
3.2% |
| Electrocardiogram Qt Prolonged |
2.7% |
| Platelet Count Decreased |
2.7% |
| Altered State Of Consciousness |
2.4% |
| Renal Impairment |
2.4% |
| Sepsis |
2.4% |
| Toxic Skin Eruption |
2.4% |
| Dementia |
2.2% |
| Renal Failure Chronic |
1.9% |
|
| Secondary |
| Gastritis |
16.2% |
| Hypertension |
14.2% |
| Myocardial Infarction |
8.4% |
| Deafness |
6.7% |
| Tonsillitis |
6.7% |
| Depression |
5.8% |
| Gastric Ulcer Haemorrhage |
4.9% |
| Angina Pectoris |
4.6% |
| Oesophagitis |
4.6% |
| Epilepsy |
3.5% |
| Fluid Replacement |
3.5% |
| Gastric Ulcer |
3.2% |
| Gastroenteritis |
3.2% |
| Reflux Oesophagitis |
2.9% |
| Cardiac Failure Chronic |
2.3% |
| Sepsis |
2.3% |
| Asthma |
1.7% |
| Constipation |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Hyperlipidaemia |
1.7% |
|
| Liver Disorder |
19.7% |
| Electrocardiogram Qt Prolonged |
11.5% |
| Pancytopenia |
8.2% |
| Renal Impairment |
8.2% |
| Abdominal Discomfort |
4.9% |
| Granulocyte Count Decreased |
4.9% |
| Idiopathic Thrombocytopenic Purpura |
4.9% |
| Platelet Count Decreased |
4.9% |
| Rhabdomyolysis |
4.9% |
| Dermatitis Exfoliative |
3.3% |
| Dyskinesia |
3.3% |
| Erythema Multiforme |
3.3% |
| Erythema Nodosum |
3.3% |
| Pyrexia |
3.3% |
| Toxic Skin Eruption |
3.3% |
| Delirium |
1.6% |
| Dermatitis Psoriasiform |
1.6% |
| Drug Interaction |
1.6% |
| Hypoglycaemia |
1.6% |
| Menstruation Irregular |
1.6% |
|
| Concomitant |
| Prophylaxis |
19.9% |
| Hypertension |
14.3% |
| Gastritis |
7.4% |
| Insomnia |
7.4% |
| Osteoporosis |
6.5% |
| Diabetes Mellitus |
5.6% |
| Chronic Hepatitis C |
5.2% |
| Constipation |
4.8% |
| Computerised Tomogram |
3.5% |
| Rhinitis |
3.5% |
| Stomatitis |
3.5% |
| Hiv Infection |
2.6% |
| Hyperlipidaemia |
2.6% |
| Prophylaxis Of Nausea And Vomiting |
2.6% |
| Acarodermatitis |
2.2% |
| Abdominal Pain Upper |
1.7% |
| Allergy Prophylaxis |
1.7% |
| Asthma |
1.7% |
| Blood Cholesterol Increased |
1.7% |
| Dry Eye |
1.7% |
|
| Enterocolitis |
8.0% |
| Femur Fracture |
8.0% |
| Interstitial Lung Disease |
8.0% |
| Renal Failure Chronic |
8.0% |
| Renal Impairment |
8.0% |
| Liver Disorder |
6.0% |
| Osteomyelitis |
6.0% |
| Primary Hyperaldosteronism |
6.0% |
| Rhabdomyolysis |
6.0% |
| Drug Eruption |
4.0% |
| Gastroenteritis |
4.0% |
| Immune Reconstitution Syndrome |
4.0% |
| Osteitis |
4.0% |
| Pancreatic Carcinoma |
4.0% |
| Pleural Effusion |
4.0% |
| Tremor |
4.0% |
| Blood Lactate Dehydrogenase Increased |
2.0% |
| Cardiac Failure |
2.0% |
| Convulsion |
2.0% |
| Death |
2.0% |
|
